90
Participants
Start Date
July 31, 2012
Primary Completion Date
October 31, 2014
Study Completion Date
November 30, 2014
JVS-100 15 mg dose Injection
Intramyocardial Injection
Placebo Injection
Intramyocardial Injection
JVS-100 30 mg dose injection
Intramyocardial Injection
Columbia University Medical Center, New York
Montefiore Medical Center, New York
University of Pennsylvania Health System, Philadelphia
Johns Hopkins University, Baltimore
University of Florida, Gainesville
Pepin Heart Institute, Tampa
Cardiology PC, Birmingham
Summa Health System, Akron
The Lindner Center at the Christ Hospital, Cincinnati
Michigan Cardiovascular Institute, Saginaw
Spectrum Health, Grand Rapids
Iowa Heart Center, Des Moines
Minneapolis Heart Institute, Minneapolis
Washington University in St. Louis, St Louis
Baylor Healthcare, Dallas
University of Utah, Salt Lake City
Lead Sponsor
Juventas Therapeutics, Inc.
INDUSTRY